148 related articles for article (PubMed ID: 32256206)
1. Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway.
Liu X; Tu Y; Wang Y; Zhou D; Chong Y; Shi L; Liu G; Zhang X; Wu S; Li H; Gao S; Niu M; Yu R
Cancer Cell Int; 2020; 20():97. PubMed ID: 32256206
[TBL] [Abstract][Full Text] [Related]
2. CRM1 inhibitor S109 suppresses cell proliferation and induces cell cycle arrest in renal cancer cells.
Liu X; Chong Y; Liu H; Han Y; Niu M
Korean J Physiol Pharmacol; 2016 Mar; 20(2):161-8. PubMed ID: 26937212
[TBL] [Abstract][Full Text] [Related]
3. CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.
Liu X; Chong Y; Tu Y; Liu N; Yue C; Qi Z; Liu H; Yao Y; Liu H; Gao S; Niu M; Yu R
J Hematol Oncol; 2016 Oct; 9(1):108. PubMed ID: 27733172
[TBL] [Abstract][Full Text] [Related]
4. Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer.
Liu X; Chong Y; Liu H; Han Y; Niu M
J Ovarian Res; 2015 Jun; 8():35. PubMed ID: 26055813
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway.
Shan Q; Li S; Cao Q; Yue C; Niu M; Chen X; Shi L; Li H; Gao S; Liang J; Yu R; Liu X
Korean J Physiol Pharmacol; 2020 May; 24(3):193-201. PubMed ID: 32392910
[TBL] [Abstract][Full Text] [Related]
6. UBA1 inhibition contributes radiosensitization of glioblastoma cells
Wu C; Shen Y; Shi L; Zhang J; Guo T; Zhou L; Wang W; Zhang X; Yu R; Liu X
Front Pharmacol; 2023; 14():1073929. PubMed ID: 36959858
[TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
Zhu Y; Culmsee C; Klumpp S; Krieglstein J
Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283
[TBL] [Abstract][Full Text] [Related]
9. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
11. DNA damage-induced NF-κB activation in human glioblastoma cells promotes miR-181b expression and cell proliferation.
Xu RX; Liu RY; Wu CM; Zhao YS; Li Y; Yao YQ; Xu YH
Cell Physiol Biochem; 2015; 35(3):913-25. PubMed ID: 25633526
[TBL] [Abstract][Full Text] [Related]
12. Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity.
Orr WS; Denbo JW; Saab KR; Ng CY; Wu J; Li K; Garner JM; Morton CL; Du Z; Pfeffer LM; Davidoff AM
PLoS One; 2013; 8(2):e51309. PubMed ID: 23408929
[TBL] [Abstract][Full Text] [Related]
13. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
14. Small GTPase RHOE/RND3, a new critical regulator of NF-κB signalling in glioblastoma multiforme?
Sun Q; Dong H; Li Y; Yuan F; Xu Y; Mao S; Xiong X; Chen Q; Liu B
Cell Prolif; 2019 Sep; 52(5):e12665. PubMed ID: 31332862
[TBL] [Abstract][Full Text] [Related]
15. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65.
Hwang SK; Baker AR; Young MR; Colburn NH
Carcinogenesis; 2014 Jul; 35(7):1469-80. PubMed ID: 24413684
[TBL] [Abstract][Full Text] [Related]
17. Dihydromyricetin promotes apoptosis, suppresses proliferation and tumor necrosis factor-α-mediated nuclear factor kappa-B activation in nasopharyngeal carcinoma CNE-2 cell.
Li CH; Ding H; Shi JL; Huang B; Ding H; Lin HG; Zeng JC; Zhao Y; Luo GQ
J Tradit Chin Med; 2021 Jun; 41(3):367-375. PubMed ID: 34114393
[TBL] [Abstract][Full Text] [Related]
18. NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma.
McFarland BC; Hong SW; Rajbhandari R; Twitty GB; Gray GK; Yu H; Benveniste EN; Nozell SE
PLoS One; 2013; 8(11):e78728. PubMed ID: 24244348
[TBL] [Abstract][Full Text] [Related]
19. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
[TBL] [Abstract][Full Text] [Related]
20. Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells.
McFarland BC; Gray GK; Nozell SE; Hong SW; Benveniste EN
Mol Cancer Res; 2013 May; 11(5):494-505. PubMed ID: 23386688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
